Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of oliceridine combined with propofol for hysteroscopy
ChiCTR2400094657Phase 4Not yet recruiting
- Sponsor
- Cixi People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine in procedural pain, sponsored by Cixi People's Hospital. Primary endpoint: ED50 and ED95 of oliceridine for suppressing cervical dilation response. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2400094657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094657.